Credelio 56.25 mg (Lotilaner TABLET (CHEWABLE)) 56.25 MG

Credelio 56.25 mg chewable tablets contain lotilaner, a parasiticide for oral administration in pets. This medication is designed to help manage flea and tick infestations, providing long-lasting protection for your pet's health.

Strength

56.25 MG

Pack Size

1/3/6

Manufacturer / TM Owner

ELANCO CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Credelio 56.25 mg chewable tablets are primarily used for the treatment and prevention of flea and tick infestations in pets. Lotilaner, the active ingredient, works to eliminate these parasites and provide continuous protection. Pet owners often seek this medication to maintain their pet's comfort and well-being by addressing common parasitic issues.

Side Effects

When administered as directed, Credelio 56.25 mg chewable tablets can help reduce the number of fleas and ticks on your pet. Many pet owners notice a significant decrease in parasitic activity within a short period. However, individual results may vary based on the severity of the infestation and the pet's overall health.

Precautions & Warnings

Always consult with a veterinarian before administering Credelio 56.25 mg chewable tablets to your pet. Ensure that the medication is stored in a cool, dry place away from direct sunlight. Monitor your pet for any signs of adverse reactions and discontinue use if necessary. Follow the recommended dosage guidelines provided by your veterinarian.

Avoid Interactions

Credelio 56.25 mg chewable tablets may interact with other medications, so it's important to inform your veterinarian about any other treatments your pet is receiving. Avoid administering this medication with other parasiticides unless directed by a veterinary professional. Always follow the guidance of your veterinarian to ensure the safety and effectiveness of the treatment.

Frequently Asked Questions

Credelio 56.25 mg chewable tablets are used to treat and prevent flea and tick infestations in pets.

Administer Credelio 56.25 mg chewable tablets orally, following the dosage instructions provided by your veterinarian.

Common side effects may include vomiting, diarrhea, and lethargy. Monitor your pet for any adverse reactions and consult your veterinarian if necessary.

Yes, Credelio 56.25 mg chewable tablets can be purchased online from authorized retailers.

The frequency of administration depends on your pet's specific needs and the severity of the infestation. Consult your veterinarian for personalized advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.